Kyntra Bio (KYNB) Current Leases (2019 - 2024)
Kyntra Bio (KYNB) posted Current Leases of $1.3 million for Q3 2024, down 91.67% sequentially from $15.5 million in Q2 2024, and down 89.12% YoY from $11.9 million in Q4 2023.
Kyntra Bio (KYNB) Current Leases (2019 - 2024) Analysis & Trends
Kyntra Bio has reported Current Leases for 6 years, with the latest figure at $1.3 million in Q3 2024.
- Quarterly Current Leases fell 89.12% year-over-year to $1.3 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $1.3 million (down 89.12% YoY) and the FY2023 annual result came in at $12.6 million, up 22.88% from the prior year.
- Current Leases declined to $1.3 million in Q3 2024 per KYNB's latest filing, from $15.5 million in the prior quarter.
- Over five years, Current Leases peaked at $15.5 million in Q2 2024 and troughed at $1.3 million in Q3 2024.
- A 5-year average of $11.1 million and a median of $11.0 million in 2022 frame the typical range for Current Leases.
- The widest YoY moves for Current Leases: up 53.43% in 2024, down 89.12% in 2024.
- Over 5 years, Current Leases stood at $12.4 million in 2020, then declined by 25.61% to $9.2 million in 2021, then climbed by 11.61% to $10.3 million in 2022, then rose by 22.88% to $12.6 million in 2023, then sank by 89.78% to $1.3 million in 2024.
- According to Business Quant data, Current Leases over the past three periods registered $1.3 million, $15.5 million, and $15.2 million for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | - |
| 10 | Kyntra Bio | 29.87 Mn | 29.87 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 15.53 Mn |
| Mar 31, 2024 | 15.23 Mn |
| Dec 31, 2023 | 12.65 Mn |
| Sep 30, 2023 | 11.88 Mn |
| Jun 30, 2023 | 11.01 Mn |
| Mar 31, 2023 | 9.93 Mn |
| Dec 31, 2022 | 10.29 Mn |
| Sep 30, 2022 | 11.50 Mn |
| Jun 30, 2022 | 10.98 Mn |
| Mar 31, 2022 | 10.98 Mn |
| Dec 31, 2021 | 9.22 Mn |
| Sep 30, 2021 | 10.83 Mn |
| Jun 30, 2021 | 10.72 Mn |
| Mar 31, 2021 | 12.48 Mn |
| Mar 31, 2020 | 12.40 Mn |
| Sep 30, 2019 | 12.15 Mn |
| Jun 30, 2019 | 12.07 Mn |
| Mar 31, 2019 | 11.77 Mn |